DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: A novel adjuvant and delivery system

被引:25
作者
Carneiro, Catarina [1 ]
Correia, Alexandra [2 ]
Collins, Tony [1 ]
Vilanova, Manuel [2 ,3 ]
Pais, Celia [1 ]
Gomes, Andreia C. [1 ,5 ]
Oliveira, M. Elisabete C. D. Real [4 ,5 ]
Sampaio, Paula [1 ]
机构
[1] Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, P-4710057 Braga, Portugal
[2] Inst Biol Mol & Celular, Oporto, Portugal
[3] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal
[4] Univ Minho, Ctr Phys CFUM, P-4710057 Braga, Portugal
[5] NanoDelivery I&D Biotechnol, Dept Biol, Braga, Portugal
关键词
DODAB:MO liposomes; Nanoparticles; Adjuvant activity; Antigen delivery systems; Candida albicans proteins; Liposome endocytosis; Humoral and cellular immune responses; Antigen protection; VACCINE DELIVERY; DENDRITIC CELLS; MEDIATED-IMMUNITY; CONJUGATE VACCINE; FUNGAL PATHOGENS; IN-VIVO; MACROPHAGES; ANTIBODY; MANNAN; LIPIDS;
D O I
10.1016/j.ejpb.2014.11.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We describe the preparation and characterization of DODAB:MO-based liposomes and demonstrate their adjuvant potential and use in antigen delivery. Liposomes loaded with Candida albicans proteins assembled as stable negatively charged spherical nanoparticles with a mean size of 280 nm. High adsorption efficiency (91.0 +/- 9.0%) is attained with high lipid concentrations. The nanoparticles were non-toxic, avidly taken up by macrophage cells and accumulated in membrane rich regions with an internalization time of 20 min. Immunized mice displayed strong humoral and cell-mediated immune responses, producing antibodies (IgGs) against specific cell wall proteins, Cht3p and Xog1p. DODAB:MO-based liposomes loaded with C. albicans proteins have an excellent immunogenic potential and can be explored for the development of an immunoprotective strategy against Candida infections. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:190 / 200
页数:11
相关论文
共 75 条
  • [1] Membrane protein crystallization in lipidic mesophases: Detergent effects
    Ai, X
    Caffrey, M
    [J]. BIOPHYSICAL JOURNAL, 2000, 79 (01) : 394 - 405
  • [2] Allison Anthony C., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P141
  • [3] Azmi Fazren, 2014, Hum Vaccin Immunother, V10, P778
  • [4] DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS
    BANGHAM, AD
    STANDISH, MM
    WATKINS, JC
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) : 238 - +
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] A lipid's eye view of membrane protein crystallization in mesophases
    Caffrey, M
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2000, 10 (04) : 486 - 497
  • [7] Bilayer-forming synthetic lipids: Drugs or carriers?
    Carmona-Ribeiro, AM
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) : 2425 - 2446
  • [8] Biomimetic particles in drug and vaccine delivery
    Carmona-Ribeiro, Ana Maria
    [J]. JOURNAL OF LIPOSOME RESEARCH, 2007, 17 (3-4) : 165 - 172
  • [9] Carmona-Ribeiro AM, 2010, INT J NANOMED, V5, P249
  • [10] A Targeted and Adjuvanted Nanocarrier Lowers the Effective Dose of Liposomal Amphotericin B and Enhances Adaptive Immunity in Murine Cutaneous Leishmaniasis
    Daftarian, Pirouz M.
    Stone, Geoffrey W.
    Kovalski, Leticia
    Kumar, Manoj
    Vosoughi, Aram
    Urbieta, Maitee
    Blackwelder, Pat
    Dikici, Emre
    Serafini, Paolo
    Duffort, Stephanie
    Boodoo, Richard
    Rodriguez-Cortes, Alheli
    Lemmon, Vance
    Deo, Sapna
    Alberola, Jordi
    Perez, Victor L.
    Daunert, Sylvia
    Ager, Arba L.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (11) : 1914 - 1922